Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Biol Med (Maywood) ; 231(4): 396-402, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16565435

ABSTRACT

We investigated short-term in vivo and in vitro effects of streptozotocin (STZ) on pancreatic beta cells. Male Wistar rats were treated with 75 mg/kg STZ, and, after 4 hrs blood glucose and insulin were measured and islet cells were isolated, cultured for 16 hrs, and challenged with 5.6 and 15.6 mM glucose. Treated rats showed hyperglycemia (approximately 14 mM) and a 70% decrease in serum insulin levels as compared with controls. Although insulin secretion by isolated beta cells from STZ-treated rats was reduced by more than 80%, in both glucose concentrations, nerve growth factor (NGF) secretion by the same cells increased 10-fold. Moreover, NGF messenger RNA (mRNA) expression increased by 30% as compared with controls. Similar results were obtained in an in vitro model of islet cells, in which cells were exposed directly to STZ for 1, 2, and 4 hrs and then challenged for 3 hrs with the same glucose concentrations. Our data strongly suggest that an early increase in NGF production and secretion by beta cells could be an endogenous protective response to maintain cell survival and that diabetes mellitus may occur when this mechanism is surpassed.


Subject(s)
Insulin-Secreting Cells/drug effects , Nerve Growth Factor/metabolism , Streptozocin/pharmacology , Animals , Apoptosis , Blood Glucose/drug effects , Body Weight/drug effects , Cell Survival/drug effects , Cells, Cultured , Gene Expression Regulation/drug effects , Insulin/blood , Insulin/genetics , Insulin-Secreting Cells/metabolism , Insulin-Secreting Cells/pathology , Male , Nerve Growth Factor/genetics , RNA, Messenger/metabolism , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...